Last reviewed · How we verify

NCT04810234

Neural Correlates of tVNS

Status unknown Last updated 22 March 2021
What this trial tests

trial testing transcutaneous vagal nerve stimulation (tVNS) in fMRI in 16 participants. Status unknown.

Timeline
1 November 2020
Primary endpoint
1 June 2021
1 June 2021

Quick facts

Lead sponsorMaastricht University Medical Center
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment16
Start date1 November 2020
Primary completion1 June 2021
Estimated completion1 June 2021
Sites2 locations across United Kingdom, Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Maastricht University Medical Center

Who can join

Adults 18 to 40, female only, with fMRI or Transcutaneous Vagal Nerve Stimulation (tVNS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transcutaneous vagal nerve stimulation (tVNS) has been applied to a number of disease areas including visceral pain, depression, cluster headache and Alzheimer's disease. However, there is marked heterogeneity in these studies pertaining to i) the anatomical site of stimulation (neck, inner concha or tragus of ear), and ii) the waveform parameters of the stimulating impulse. This exploratory cross-sectional study will address these knowledge gaps by comparative functional neuroimaging of the neural correlates of tVNS with disparate anatomical sites and electrical waveform characteristics during rest in healthy participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for fMRI

Currently open trials in the same condition.

Other Maastricht University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04810234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing